| 0 |
DEVICE WIRELESS COMMUNICATION ISSUE |
68 |
0.2625 |
| 1 |
REMOVAL OF FOREIGN BODY |
22 |
0.2391 |
| 2 |
TRACHEAL DEVIATION |
18 |
0.2045 |
| 3 |
SCHIZENCEPHALY |
8 |
0.1778 |
| 4 |
DEVICE MAINTENANCE ISSUE |
98 |
0.1667 |
| 5 |
UNEVALUABLE DEVICE ISSUE |
13 |
0.1461 |
| 6 |
CEREBRAL HAEMORRHAGE FOETAL |
8 |
0.1311 |
| 7 |
INFUSION SITE INJURY |
23 |
0.1307 |
| 8 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
136 |
0.1281 |
| 9 |
INFUSION SITE DRYNESS |
6 |
0.1111 |
| 10 |
VASCULAR MALFORMATION |
20 |
0.0952 |
| 11 |
SULPHAEMOGLOBINAEMIA |
11 |
0.0948 |
| 12 |
PHRENIC NERVE PARALYSIS |
19 |
0.0868 |
| 13 |
INFUSION SITE DISCHARGE |
145 |
0.0826 |
| 14 |
PARANASAL CYST |
20 |
0.0823 |
| 15 |
INFUSION SITE SCAB |
10 |
0.0813 |
| 16 |
INFUSION SITE STREAKING |
7 |
0.0805 |
| 17 |
INFUSION SITE IRRITATION |
100 |
0.0778 |
| 18 |
INFUSION SITE INDURATION |
112 |
0.0755 |
| 19 |
TRIGEMINO-CARDIAC REFLEX |
6 |
0.0741 |
| 20 |
INFUSION SITE INFLAMMATION |
52 |
0.0737 |
| 21 |
INFUSION SITE HAEMORRHAGE |
233 |
0.0708 |
| 22 |
INFUSION SITE WARMTH |
86 |
0.0701 |
| 23 |
ADMINISTRATION SITE ODOUR |
5 |
0.0658 |
| 24 |
INFUSION SITE NODULE |
63 |
0.0656 |
| 25 |
INFUSION SITE INFECTION |
150 |
0.0645 |
| 26 |
PATIENT DISSATISFACTION WITH DEVICE |
16 |
0.0635 |
| 27 |
INFUSION SITE DISCOLOURATION |
55 |
0.0625 |
| 28 |
INFUSION SITE PAIN |
792 |
0.0614 |
| 29 |
INSPIRATORY CAPACITY DECREASED |
17 |
0.0614 |
| 30 |
BODY TINEA |
34 |
0.0607 |
| 31 |
INFUSION SITE ERYTHEMA |
494 |
0.0585 |
| 32 |
INFUSION SITE HYPERSENSITIVITY |
7 |
0.0583 |
| 33 |
ANAL INFLAMMATION |
36 |
0.0563 |
| 34 |
DEVICE INFUSION ISSUE |
137 |
0.0552 |
| 35 |
INFUSION SITE SWELLING |
345 |
0.0548 |
| 36 |
INFUSION SITE CELLULITIS |
27 |
0.0511 |
| 37 |
SARS-COV-2 TEST NEGATIVE |
32 |
0.0474 |
| 38 |
GENITAL EROSION |
14 |
0.0471 |
| 39 |
ACUTE MACULAR NEURORETINOPATHY |
8 |
0.0468 |
| 40 |
INFUSION SITE DISCOMFORT |
43 |
0.0415 |
| 41 |
ADMINISTRATION RELATED REACTION |
8 |
0.0410 |
| 42 |
CANDIDA ENDOPHTHALMITIS |
5 |
0.0410 |
| 43 |
INFUSION SITE REACTION |
113 |
0.0378 |
| 44 |
SLEEP DISORDER THERAPY |
7 |
0.0354 |
| 45 |
MATERNAL EXPOSURE DURING DELIVERY |
34 |
0.0343 |
| 46 |
APPENDICOLITH |
13 |
0.0336 |
| 47 |
INFUSION SITE PRURITUS |
105 |
0.0332 |
| 48 |
INFUSION SITE VESICLES |
17 |
0.0323 |
| 49 |
INFUSION SITE MASS |
35 |
0.0322 |
| 50 |
CENTRAL PAIN SYNDROME |
8 |
0.0302 |
| 51 |
INFUSION SITE RASH |
40 |
0.0291 |
| 52 |
TONGUE SPASM |
9 |
0.0288 |
| 53 |
BILE ACIDS INCREASED |
5 |
0.0282 |
| 54 |
ANALGESIC THERAPY |
9 |
0.0280 |
| 55 |
INFUSION SITE SCAR |
12 |
0.0271 |
| 56 |
PAINFUL EJACULATION |
6 |
0.0265 |
| 57 |
ADULTERATED PRODUCT |
5 |
0.0250 |
| 58 |
PNEUMOCEPHALUS |
8 |
0.0242 |
| 59 |
CATHETER SITE IRRITATION |
8 |
0.0240 |
| 60 |
INFUSION SITE ABSCESS |
12 |
0.0238 |
| 61 |
DEVICE POWER SOURCE ISSUE |
69 |
0.0236 |
| 62 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
13 |
0.0232 |
| 63 |
INFUSION SITE BRUISING |
50 |
0.0231 |
| 64 |
DEVICE ALARM ISSUE |
42 |
0.0231 |
| 65 |
PROSTATIC PAIN |
9 |
0.0221 |
| 66 |
BLOOD CHOLINESTERASE DECREASED |
6 |
0.0219 |
| 67 |
MASTOIDITIS |
21 |
0.0214 |
| 68 |
FOETAL EXPOSURE DURING DELIVERY |
14 |
0.0206 |
| 69 |
INHIBITORY DRUG INTERACTION |
32 |
0.0202 |
| 70 |
METHAEMOGLOBINAEMIA |
43 |
0.0186 |
| 71 |
NEUROLOGIC NEGLECT SYNDROME |
10 |
0.0180 |
| 72 |
INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT |
18 |
0.0179 |
| 73 |
DRUG THERAPY |
6 |
0.0177 |
| 74 |
TOXIC ANTERIOR SEGMENT SYNDROME |
18 |
0.0165 |
| 75 |
DEVICE CONNECTION ISSUE |
33 |
0.0156 |
| 76 |
PURULENT DISCHARGE |
66 |
0.0154 |
| 77 |
MUCOSAL EROSION |
14 |
0.0154 |
| 78 |
INFECTION SUSCEPTIBILITY INCREASED |
32 |
0.0146 |
| 79 |
DEVICE ELECTRICAL FINDING |
10 |
0.0141 |
| 80 |
PROCEDURAL HYPOTENSION |
12 |
0.0141 |
| 81 |
EMBOLIA CUTIS MEDICAMENTOSA |
11 |
0.0138 |
| 82 |
FOREIGN BODY IN RESPIRATORY TRACT |
18 |
0.0137 |
| 83 |
SPINAL CORD INFARCTION |
6 |
0.0136 |
| 84 |
INFUSION SITE URTICARIA |
9 |
0.0134 |
| 85 |
PARTIAL SEIZURES WITH SECONDARY GENERALISATION |
6 |
0.0128 |
| 86 |
MECHANICAL URTICARIA |
6 |
0.0128 |
| 87 |
OPEN FRACTURE |
6 |
0.0124 |
| 88 |
HYPOPROTEINAEMIA |
23 |
0.0121 |
| 89 |
INFUSION SITE OEDEMA |
10 |
0.0120 |
| 90 |
INFANTILE APNOEA |
9 |
0.0110 |
| 91 |
HYPERTHERMIA MALIGNANT |
16 |
0.0107 |
| 92 |
CATHETER SITE SWELLING |
10 |
0.0107 |
| 93 |
ANAPHYLACTOID SHOCK |
5 |
0.0106 |
| 94 |
CAROTID ARTERY THROMBOSIS |
9 |
0.0106 |
| 95 |
INFUSION SITE HAEMATOMA |
5 |
0.0105 |
| 96 |
CAUDA EQUINA SYNDROME |
8 |
0.0104 |
| 97 |
EXTRADURAL ABSCESS |
8 |
0.0102 |
| 98 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
9 |
0.0099 |
| 99 |
KOUNIS SYNDROME |
22 |
0.0097 |
| 100 |
DERMATITIS CONTACT |
110 |
0.0096 |
| 101 |
DEVICE USE CONFUSION |
5 |
0.0096 |
| 102 |
BRAIN STEM SYNDROME |
7 |
0.0093 |
| 103 |
CATHETER SITE ERYTHEMA |
19 |
0.0089 |
| 104 |
PERINEAL PAIN |
6 |
0.0084 |
| 105 |
DRUG-DISEASE INTERACTION |
6 |
0.0082 |
| 106 |
DEVICE LOOSENING |
7 |
0.0081 |
| 107 |
CATHETER SITE DISCHARGE |
9 |
0.0080 |
| 108 |
HYPERPHOSPHATAEMIA |
17 |
0.0079 |
| 109 |
SUSPECTED PRODUCT CONTAMINATION |
8 |
0.0079 |
| 110 |
DEVICE OCCLUSION |
111 |
0.0079 |
| 111 |
PRODUCT PACKAGING CONFUSION |
19 |
0.0078 |
| 112 |
CHEMICAL BURN |
9 |
0.0078 |
| 113 |
HAEMOGLOBIN INCREASED |
33 |
0.0072 |
| 114 |
OXYGEN CONSUMPTION INCREASED |
17 |
0.0071 |
| 115 |
TONGUE MOVEMENT DISTURBANCE |
6 |
0.0070 |
| 116 |
DEVICE PLACEMENT ISSUE |
25 |
0.0070 |
| 117 |
OTITIS MEDIA |
23 |
0.0070 |
| 118 |
DEVICE FAILURE |
106 |
0.0070 |
| 119 |
ADJUSTMENT DISORDER |
9 |
0.0069 |
| 120 |
HYPERVOLAEMIA |
34 |
0.0069 |
| 121 |
FOETAL DEATH |
35 |
0.0067 |
| 122 |
ANAESTHETIC COMPLICATION |
18 |
0.0067 |
| 123 |
HYPERURICAEMIA |
27 |
0.0066 |
| 124 |
TONGUE INJURY |
6 |
0.0064 |
| 125 |
POST HERPETIC NEURALGIA |
9 |
0.0063 |
| 126 |
PROCTALGIA |
38 |
0.0059 |
| 127 |
CONSCIOUSNESS FLUCTUATING |
6 |
0.0057 |
| 128 |
DEVICE PHYSICAL PROPERTY ISSUE |
44 |
0.0057 |
| 129 |
PRODUCT LEAKAGE |
32 |
0.0057 |
| 130 |
CATHETER SITE PRURITUS |
5 |
0.0057 |
| 131 |
INCORRECT PRODUCT FORMULATION ADMINISTERED |
5 |
0.0056 |
| 132 |
CATHETER SITE HAEMORRHAGE |
14 |
0.0056 |
| 133 |
GLUCOSE TOLERANCE IMPAIRED |
33 |
0.0056 |
| 134 |
FOREIGN BODY |
22 |
0.0055 |
| 135 |
BLOOD PHOSPHORUS INCREASED |
15 |
0.0055 |
| 136 |
DRUG TITRATION ERROR |
14 |
0.0054 |
| 137 |
ACCIDENTAL DEATH |
10 |
0.0054 |
| 138 |
STRESS CARDIOMYOPATHY |
31 |
0.0053 |
| 139 |
HYPOCHLORAEMIA |
6 |
0.0051 |
| 140 |
TONGUE HAEMORRHAGE |
6 |
0.0051 |
| 141 |
CATHETER SITE PAIN |
13 |
0.0050 |
| 142 |
PRODUCT ADMINISTRATION INTERRUPTED |
39 |
0.0050 |
| 143 |
DEVICE KINK |
18 |
0.0049 |
| 144 |
ANAPHYLACTIC SHOCK |
127 |
0.0049 |
| 145 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
16 |
0.0048 |
| 146 |
SLEEP DEFICIT |
10 |
0.0047 |
| 147 |
THERAPY PARTIAL RESPONDER |
73 |
0.0047 |
| 148 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
12 |
0.0046 |
| 149 |
FACIAL SPASM |
5 |
0.0045 |
| 150 |
MACULAR HOLE |
6 |
0.0045 |
| 151 |
PUPILLARY REFLEX IMPAIRED |
8 |
0.0043 |
| 152 |
JOINT INSTABILITY |
6 |
0.0043 |
| 153 |
OXYGEN THERAPY |
7 |
0.0043 |
| 154 |
INCORRECT DRUG ADMINISTRATION RATE |
18 |
0.0042 |
| 155 |
FOOD INTERACTION |
7 |
0.0040 |
| 156 |
HYPERLIPIDAEMIA |
47 |
0.0039 |
| 157 |
ARTHRITIS BACTERIAL |
16 |
0.0039 |
| 158 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
45 |
0.0039 |
| 159 |
PURPURA |
34 |
0.0038 |
| 160 |
LIVE BIRTH |
32 |
0.0038 |
| 161 |
PERSONALITY DISORDER |
10 |
0.0038 |
| 162 |
SUBSTANCE USE DISORDER |
12 |
0.0038 |
| 163 |
THERAPY NON-RESPONDER |
168 |
0.0037 |
| 164 |
LYMPHOCYTE COUNT DECREASED |
66 |
0.0037 |
| 165 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
14 |
0.0037 |
| 166 |
VITREOUS HAEMORRHAGE |
10 |
0.0036 |
| 167 |
GENERALISED TONIC-CLONIC SEIZURE |
59 |
0.0036 |
| 168 |
IMPAIRED QUALITY OF LIFE |
51 |
0.0035 |
| 169 |
DEVICE INFORMATION OUTPUT ISSUE |
27 |
0.0035 |
| 170 |
PAIN IN JAW |
98 |
0.0035 |
| 171 |
STATUS EPILEPTICUS |
39 |
0.0034 |
| 172 |
PROTEIN TOTAL DECREASED |
13 |
0.0034 |
| 173 |
BILIRUBIN CONJUGATED INCREASED |
8 |
0.0034 |
| 174 |
VENTRICULAR FIBRILLATION |
38 |
0.0034 |
| 175 |
PULSE ABSENT |
16 |
0.0034 |
| 176 |
INJECTION SITE INFECTION |
11 |
0.0033 |
| 177 |
RESPIRATORY ACIDOSIS |
13 |
0.0033 |
| 178 |
VASCULAR DEVICE INFECTION |
15 |
0.0033 |
| 179 |
IMMUNE THROMBOCYTOPENIA |
15 |
0.0033 |
| 180 |
ACCIDENT |
39 |
0.0033 |
| 181 |
BLOOD PRESSURE IMMEASURABLE |
5 |
0.0033 |
| 182 |
SUPRAVENTRICULAR EXTRASYSTOLES |
11 |
0.0033 |
| 183 |
DRUG TOLERANCE DECREASED |
9 |
0.0032 |
| 184 |
HYPOTONIA NEONATAL |
5 |
0.0032 |
| 185 |
RETINAL ARTERY OCCLUSION |
8 |
0.0032 |
| 186 |
HYPERAESTHESIA |
26 |
0.0032 |
| 187 |
DEVICE DISLOCATION |
137 |
0.0031 |
| 188 |
CANCER PAIN |
8 |
0.0031 |
| 189 |
BENIGN PROSTATIC HYPERPLASIA |
16 |
0.0031 |
| 190 |
HYPOALBUMINAEMIA |
24 |
0.0031 |
| 191 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
9 |
0.0031 |
| 192 |
CARDIOVASCULAR INSUFFICIENCY |
5 |
0.0031 |
| 193 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
8 |
0.0030 |
| 194 |
MIOSIS |
24 |
0.0030 |
| 195 |
POOR QUALITY SLEEP |
64 |
0.0030 |
| 196 |
PULMONARY ARTERIAL HYPERTENSION |
43 |
0.0030 |
| 197 |
BLOOD SODIUM INCREASED |
8 |
0.0030 |
| 198 |
DEAFNESS BILATERAL |
5 |
0.0029 |
| 199 |
GAZE PALSY |
5 |
0.0029 |
| 200 |
BLOOD PH DECREASED |
5 |
0.0029 |
| 201 |
LACUNAR INFARCTION |
7 |
0.0029 |
| 202 |
CLONUS |
8 |
0.0029 |
| 203 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
50 |
0.0029 |
| 204 |
APNOEA |
22 |
0.0028 |
| 205 |
VOMITING PROJECTILE |
8 |
0.0028 |
| 206 |
PRODUCT CONTAMINATION PHYSICAL |
7 |
0.0028 |
| 207 |
SEASONAL ALLERGY |
39 |
0.0028 |
| 208 |
BLOOD PHOSPHORUS DECREASED |
10 |
0.0027 |
| 209 |
CONDUCTION DISORDER |
5 |
0.0027 |
| 210 |
BLOOD CHLORIDE DECREASED |
7 |
0.0027 |
| 211 |
HYPERCAPNIA |
8 |
0.0027 |
| 212 |
CYSTOID MACULAR OEDEMA |
5 |
0.0027 |
| 213 |
MYDRIASIS |
34 |
0.0026 |
| 214 |
CARDIOGENIC SHOCK |
38 |
0.0026 |
| 215 |
DEVICE USE ERROR |
91 |
0.0026 |
| 216 |
INJECTION SITE INFLAMMATION |
13 |
0.0026 |
| 217 |
DIZZINESS POSTURAL |
25 |
0.0026 |
| 218 |
RESPIRATORY TRACT INFECTION VIRAL |
6 |
0.0026 |
| 219 |
HYPOPHOSPHATAEMIA |
19 |
0.0026 |
| 220 |
PULMONARY HYPERTENSION |
53 |
0.0025 |
| 221 |
SKIN NECROSIS |
13 |
0.0025 |
| 222 |
HYPOCALCAEMIA |
47 |
0.0025 |
| 223 |
OXYGEN SATURATION ABNORMAL |
7 |
0.0025 |
| 224 |
HAEMORRHOIDS |
48 |
0.0025 |
| 225 |
PARAPLEGIA |
7 |
0.0024 |
| 226 |
BLOOD URIC ACID INCREASED |
14 |
0.0024 |
| 227 |
ARTHRITIS INFECTIVE |
11 |
0.0024 |
| 228 |
BUNDLE BRANCH BLOCK LEFT |
10 |
0.0024 |
| 229 |
CARDIAC ARREST |
194 |
0.0023 |
| 230 |
SINUS TACHYCARDIA |
33 |
0.0023 |
| 231 |
BODY TEMPERATURE INCREASED |
47 |
0.0023 |
| 232 |
BLOOD BLISTER |
7 |
0.0022 |
| 233 |
CORNEAL OEDEMA |
5 |
0.0022 |
| 234 |
BONE LESION |
8 |
0.0022 |
| 235 |
SUPRAVENTRICULAR TACHYCARDIA |
21 |
0.0022 |
| 236 |
HYPOXIA |
77 |
0.0022 |
| 237 |
DEAFNESS NEUROSENSORY |
7 |
0.0021 |
| 238 |
HYPERTONIA |
12 |
0.0021 |
| 239 |
BLOOD LACTIC ACID INCREASED |
11 |
0.0021 |
| 240 |
NEUTROPHIL COUNT DECREASED |
85 |
0.0021 |
| 241 |
BRADYCARDIA |
110 |
0.0021 |
| 242 |
FINE MOTOR SKILL DYSFUNCTION |
6 |
0.0021 |
| 243 |
NYSTAGMUS |
11 |
0.0021 |
| 244 |
OXYGEN SATURATION DECREASED |
116 |
0.0021 |
| 245 |
DEVICE LEAKAGE |
89 |
0.0021 |
| 246 |
STRIDOR |
6 |
0.0020 |
| 247 |
IMPAIRED WORK ABILITY |
43 |
0.0020 |
| 248 |
GINGIVAL PAIN |
16 |
0.0020 |
| 249 |
IRON DEFICIENCY |
9 |
0.0020 |
| 250 |
SUSPECTED OFF LABEL USE |
9 |
0.0020 |
| 251 |
PALLOR |
53 |
0.0019 |
| 252 |
TRISMUS |
10 |
0.0019 |
| 253 |
APPENDICITIS |
18 |
0.0019 |
| 254 |
HYPOAESTHESIA ORAL |
29 |
0.0019 |
| 255 |
ORAL HERPES |
37 |
0.0019 |
| 256 |
OBSTRUCTIVE AIRWAYS DISORDER |
21 |
0.0019 |
| 257 |
DYSPNOEA EXERTIONAL |
71 |
0.0019 |
| 258 |
SENSORY LOSS |
15 |
0.0019 |
| 259 |
MYASTHENIA GRAVIS |
15 |
0.0019 |
| 260 |
ANAL ABSCESS |
10 |
0.0019 |
| 261 |
ANAPHYLACTIC REACTION |
102 |
0.0018 |
| 262 |
TOXIC EPIDERMAL NECROLYSIS |
28 |
0.0018 |
| 263 |
HICCUPS |
15 |
0.0018 |
| 264 |
UNRESPONSIVE TO STIMULI |
47 |
0.0018 |
| 265 |
HYPOKALAEMIA |
84 |
0.0018 |
| 266 |
VENTRICULAR TACHYCARDIA |
30 |
0.0018 |
| 267 |
DRUG USE DISORDER |
15 |
0.0018 |
| 268 |
ENDOTRACHEAL INTUBATION |
5 |
0.0018 |
| 269 |
MENINGITIS ASEPTIC |
8 |
0.0018 |
| 270 |
INFUSION SITE EXTRAVASATION |
11 |
0.0018 |
| 271 |
MOTOR DYSFUNCTION |
18 |
0.0018 |
| 272 |
BLOOD ALBUMIN DECREASED |
14 |
0.0018 |
| 273 |
SENSITIVE SKIN |
13 |
0.0018 |
| 274 |
NEUTROPHIL COUNT INCREASED |
18 |
0.0018 |
| 275 |
EYE MOVEMENT DISORDER |
12 |
0.0018 |
| 276 |
HYPOGLYCAEMIC COMA |
5 |
0.0017 |
| 277 |
FEBRILE NEUTROPENIA |
115 |
0.0017 |
| 278 |
LOCALISED OEDEMA |
8 |
0.0017 |
| 279 |
LUMBAR SPINAL STENOSIS |
5 |
0.0017 |
| 280 |
DEVICE ADHESION ISSUE |
26 |
0.0017 |
| 281 |
ARTERIOSCLEROSIS CORONARY ARTERY |
11 |
0.0017 |
| 282 |
GANGRENE |
10 |
0.0017 |
| 283 |
TORSADE DE POINTES |
13 |
0.0017 |
| 284 |
ARTERIAL OCCLUSIVE DISEASE |
13 |
0.0017 |
| 285 |
CRANIOCEREBRAL INJURY |
5 |
0.0017 |
| 286 |
FACIAL PARALYSIS |
14 |
0.0016 |
| 287 |
DYSCHEZIA |
5 |
0.0016 |
| 288 |
WRONG PRODUCT ADMINISTERED |
11 |
0.0016 |
| 289 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
5 |
0.0016 |
| 290 |
BRAIN DEATH |
5 |
0.0016 |
| 291 |
PROTEIN URINE PRESENT |
8 |
0.0016 |
| 292 |
SPINAL OSTEOARTHRITIS |
14 |
0.0016 |
| 293 |
CIRCULATORY COLLAPSE |
27 |
0.0016 |
| 294 |
RIGHT VENTRICULAR FAILURE |
11 |
0.0016 |
| 295 |
CONJUNCTIVITIS |
29 |
0.0016 |
| 296 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
8 |
0.0016 |
| 297 |
HYPERTRIGLYCERIDAEMIA |
9 |
0.0015 |
| 298 |
PNEUMONIA FUNGAL |
6 |
0.0015 |
| 299 |
DEVICE ISSUE |
136 |
0.0015 |
| 300 |
POISONING |
19 |
0.0015 |
| 301 |
RESPIRATORY TRACT CONGESTION |
24 |
0.0015 |
| 302 |
TRICUSPID VALVE INCOMPETENCE |
12 |
0.0015 |
| 303 |
ENDOPHTHALMITIS |
9 |
0.0015 |
| 304 |
SKIN ABRASION |
7 |
0.0015 |
| 305 |
SUBSTANCE ABUSE |
12 |
0.0015 |
| 306 |
LARYNGEAL OEDEMA |
9 |
0.0015 |
| 307 |
SELF-MEDICATION |
6 |
0.0015 |
| 308 |
PARAESTHESIA ORAL |
21 |
0.0015 |
| 309 |
RESPIRATORY ARREST |
40 |
0.0014 |
| 310 |
HEMIPLEGIA |
12 |
0.0014 |
| 311 |
SKIN DISORDER |
48 |
0.0014 |
| 312 |
PROCEDURAL COMPLICATION |
11 |
0.0014 |
| 313 |
CELLULITIS |
72 |
0.0014 |
| 314 |
NEUROTOXICITY |
25 |
0.0014 |
| 315 |
LOW DENSITY LIPOPROTEIN INCREASED |
11 |
0.0014 |
| 316 |
SUDDEN DEATH |
15 |
0.0014 |
| 317 |
HYPERPYREXIA |
6 |
0.0014 |
| 318 |
FIBRIN D DIMER INCREASED |
5 |
0.0014 |
| 319 |
NEUROLOGICAL SYMPTOM |
8 |
0.0014 |
| 320 |
NEURALGIA |
34 |
0.0014 |
| 321 |
ABNORMAL SENSATION IN EYE |
6 |
0.0014 |
| 322 |
MOUTH SWELLING |
8 |
0.0014 |
| 323 |
PRODUCT LABEL CONFUSION |
8 |
0.0014 |
| 324 |
MOUTH HAEMORRHAGE |
10 |
0.0014 |
| 325 |
ACUTE RESPIRATORY FAILURE |
26 |
0.0014 |
| 326 |
WEIGHT FLUCTUATION |
14 |
0.0013 |
| 327 |
GASTROENTERITIS VIRAL |
24 |
0.0013 |
| 328 |
GASTROINTESTINAL MOTILITY DISORDER |
7 |
0.0013 |
| 329 |
BUNDLE BRANCH BLOCK RIGHT |
6 |
0.0013 |
| 330 |
SALIVARY HYPERSECRETION |
13 |
0.0013 |
| 331 |
HEMIPARESIS |
22 |
0.0013 |
| 332 |
NORMAL NEWBORN |
7 |
0.0013 |
| 333 |
MOUTH ULCERATION |
27 |
0.0013 |
| 334 |
DEAFNESS UNILATERAL |
7 |
0.0013 |
| 335 |
CARDIO-RESPIRATORY ARREST |
53 |
0.0013 |
| 336 |
BRONCHOSPASM |
18 |
0.0013 |
| 337 |
INTRACRANIAL PRESSURE INCREASED |
7 |
0.0013 |
| 338 |
NEUTROPHILIA |
7 |
0.0012 |
| 339 |
FULL BLOOD COUNT ABNORMAL |
13 |
0.0012 |
| 340 |
POLYURIA |
10 |
0.0012 |
| 341 |
ANAPHYLACTOID REACTION |
5 |
0.0012 |
| 342 |
DIABETIC NEUROPATHY |
6 |
0.0012 |
| 343 |
HYPOTENSION |
243 |
0.0012 |
| 344 |
PERICARDIAL EFFUSION |
28 |
0.0012 |
| 345 |
ACCIDENTAL OVERDOSE |
44 |
0.0012 |
| 346 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
34 |
0.0012 |
| 347 |
LEFT VENTRICULAR DYSFUNCTION |
8 |
0.0012 |
| 348 |
FEELING OF BODY TEMPERATURE CHANGE |
7 |
0.0012 |
| 349 |
PLATELET COUNT DECREASED |
127 |
0.0012 |
| 350 |
SINUS CONGESTION |
16 |
0.0012 |
| 351 |
FLUID RETENTION |
60 |
0.0012 |
| 352 |
BACTERIAL INFECTION |
22 |
0.0012 |
| 353 |
ENDOCARDITIS |
6 |
0.0012 |
| 354 |
LACERATION |
11 |
0.0012 |
| 355 |
NERVE INJURY |
13 |
0.0012 |
| 356 |
DYSARTHRIA |
44 |
0.0012 |
| 357 |
DEVICE MALFUNCTION |
82 |
0.0012 |
| 358 |
ALTERED STATE OF CONSCIOUSNESS |
25 |
0.0012 |
| 359 |
HYPOMAGNESAEMIA |
16 |
0.0011 |
| 360 |
ATELECTASIS |
11 |
0.0011 |
| 361 |
SHOCK |
26 |
0.0011 |
| 362 |
RESPIRATORY RATE INCREASED |
10 |
0.0011 |
| 363 |
ASCITES |
33 |
0.0011 |
| 364 |
QUALITY OF LIFE DECREASED |
15 |
0.0011 |
| 365 |
BONE DENSITY DECREASED |
35 |
0.0011 |
| 366 |
MENTAL STATUS CHANGES |
31 |
0.0011 |
| 367 |
SPINAL PAIN |
13 |
0.0011 |
| 368 |
TACHYPNOEA |
15 |
0.0011 |
| 369 |
INTRAOCULAR PRESSURE INCREASED |
14 |
0.0011 |
| 370 |
BLINDNESS TRANSIENT |
8 |
0.0011 |
| 371 |
EYELID PTOSIS |
11 |
0.0011 |
| 372 |
POOR QUALITY DRUG ADMINISTERED |
7 |
0.0011 |
| 373 |
OEDEMA |
58 |
0.0011 |
| 374 |
RESPIRATORY DEPRESSION |
13 |
0.0011 |
| 375 |
MUSCLE SPASTICITY |
13 |
0.0011 |
| 376 |
EXERCISE TOLERANCE DECREASED |
6 |
0.0010 |
| 377 |
AFFECT LABILITY |
10 |
0.0010 |
| 378 |
HAEMOLYSIS |
8 |
0.0010 |
| 379 |
ENTEROCOCCAL INFECTION |
5 |
0.0010 |
| 380 |
SINUS BRADYCARDIA |
10 |
0.0010 |
| 381 |
DERMATITIS ALLERGIC |
13 |
0.0010 |
| 382 |
RALES |
6 |
0.0010 |
| 383 |
METABOLIC ACIDOSIS |
33 |
0.0010 |
| 384 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
8 |
0.0010 |
| 385 |
MYELOSUPPRESSION |
37 |
0.0010 |
| 386 |
HYPOVOLAEMIA |
6 |
0.0010 |
| 387 |
GROIN PAIN |
9 |
0.0010 |
| 388 |
DRUG ERUPTION |
18 |
0.0010 |
| 389 |
JOINT EFFUSION |
7 |
0.0010 |
| 390 |
SINUS DISORDER |
20 |
0.0010 |
| 391 |
CATARACT |
60 |
0.0010 |
| 392 |
HYPERTRANSAMINASAEMIA |
7 |
0.0010 |
| 393 |
ASPIRATION |
11 |
0.0010 |
| 394 |
HYPERNATRAEMIA |
5 |
0.0010 |
| 395 |
STAPHYLOCOCCAL INFECTION |
33 |
0.0010 |
| 396 |
TOOTHACHE |
18 |
0.0010 |
| 397 |
BLOOD PRESSURE DECREASED |
66 |
0.0010 |
| 398 |
DUODENAL ULCER |
7 |
0.0010 |
| 399 |
INJECTION SITE VESICLES |
6 |
0.0010 |
| 400 |
MIGRAINE |
94 |
0.0010 |
| 401 |
TOXICITY TO VARIOUS AGENTS |
166 |
0.0010 |
| 402 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
54 |
0.0010 |
| 403 |
DEVICE DIFFICULT TO USE |
65 |
0.0010 |
| 404 |
PARALYSIS |
14 |
0.0010 |
| 405 |
HYPONATRAEMIA |
55 |
0.0010 |
| 406 |
CACHEXIA |
5 |
0.0010 |
| 407 |
DEVICE USE ISSUE |
17 |
0.0010 |
| 408 |
MUSCULOSKELETAL CHEST PAIN |
15 |
0.0010 |
| 409 |
SCOLIOSIS |
6 |
0.0010 |
| 410 |
VENTRICULAR EXTRASYSTOLES |
10 |
0.0010 |
| 411 |
HERPES ZOSTER |
55 |
0.0010 |
| 412 |
BRAIN FOG |
15 |
0.0010 |
| 413 |
BLEPHAROSPASM |
6 |
0.0010 |
| 414 |
PHOTOPSIA |
6 |
0.0009 |
| 415 |
PNEUMOTHORAX |
15 |
0.0009 |
| 416 |
RASH MACULO-PAPULAR |
21 |
0.0009 |
| 417 |
ENTERITIS |
6 |
0.0009 |
| 418 |
EPISTAXIS |
70 |
0.0009 |
| 419 |
C-REACTIVE PROTEIN INCREASED |
34 |
0.0009 |
| 420 |
DRUG INTERACTION |
148 |
0.0009 |
| 421 |
WHITE BLOOD CELL COUNT DECREASED |
101 |
0.0009 |
| 422 |
INJECTION SITE DISCHARGE |
5 |
0.0009 |
| 423 |
APHASIA |
28 |
0.0009 |
| 424 |
HAEMODYNAMIC INSTABILITY |
7 |
0.0009 |
| 425 |
LIPASE INCREASED |
7 |
0.0009 |
| 426 |
COLD SWEAT |
16 |
0.0009 |
| 427 |
ATRIOVENTRICULAR BLOCK |
7 |
0.0009 |
| 428 |
PALPITATIONS |
106 |
0.0009 |
| 429 |
ASPARTATE AMINOTRANSFERASE INCREASED |
48 |
0.0009 |
| 430 |
PREMATURE BABY |
27 |
0.0009 |
| 431 |
BLOOD UREA INCREASED |
15 |
0.0009 |
| 432 |
MALNUTRITION |
10 |
0.0009 |
| 433 |
SNEEZING |
20 |
0.0009 |
| 434 |
ACUTE PULMONARY OEDEMA |
5 |
0.0009 |
| 435 |
SLEEP APNOEA SYNDROME |
17 |
0.0009 |
| 436 |
BLOOD CALCIUM DECREASED |
10 |
0.0009 |
| 437 |
ILEUS |
11 |
0.0009 |
| 438 |
BURNING SENSATION |
62 |
0.0009 |
| 439 |
ILLNESS |
91 |
0.0009 |
| 440 |
RENAL CYST |
7 |
0.0009 |
| 441 |
SKIN HAEMORRHAGE |
13 |
0.0009 |
| 442 |
BLISTER |
49 |
0.0009 |
| 443 |
RESPIRATION ABNORMAL |
6 |
0.0009 |
| 444 |
RETINAL DETACHMENT |
8 |
0.0009 |
| 445 |
RESPIRATORY DISTRESS |
24 |
0.0009 |
| 446 |
IRON DEFICIENCY ANAEMIA |
8 |
0.0009 |
| 447 |
GRAND MAL CONVULSION |
8 |
0.0009 |
| 448 |
ENTEROCOLITIS |
5 |
0.0009 |
| 449 |
HYPERVENTILATION |
5 |
0.0009 |
| 450 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
34 |
0.0009 |
| 451 |
TACHYCARDIA |
76 |
0.0009 |
| 452 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
15 |
0.0008 |
| 453 |
CYSTITIS |
27 |
0.0008 |
| 454 |
EATING DISORDER |
18 |
0.0008 |
| 455 |
BACTERAEMIA |
10 |
0.0008 |
| 456 |
EYE INFLAMMATION |
8 |
0.0008 |
| 457 |
SEROTONIN SYNDROME |
16 |
0.0008 |
| 458 |
MEDICATION ERROR |
46 |
0.0008 |
| 459 |
CYANOSIS |
13 |
0.0008 |
| 460 |
RESTLESS LEGS SYNDROME |
15 |
0.0008 |
| 461 |
HAEMOPTYSIS |
23 |
0.0008 |
| 462 |
SEIZURE |
95 |
0.0008 |
| 463 |
PHARYNGEAL SWELLING |
8 |
0.0008 |
| 464 |
ABDOMINAL DISTENSION |
85 |
0.0008 |
| 465 |
VITREOUS FLOATERS |
8 |
0.0008 |
| 466 |
SMALL INTESTINAL OBSTRUCTION |
10 |
0.0008 |
| 467 |
PYELONEPHRITIS |
7 |
0.0008 |
| 468 |
DYSPNOEA |
452 |
0.0008 |
| 469 |
ALANINE AMINOTRANSFERASE INCREASED |
49 |
0.0008 |
| 470 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
7 |
0.0008 |
| 471 |
APHONIA |
11 |
0.0008 |
| 472 |
MUSCULOSKELETAL DISORDER |
15 |
0.0008 |
| 473 |
DISCOMFORT |
48 |
0.0008 |
| 474 |
DRUG LEVEL INCREASED |
13 |
0.0008 |
| 475 |
INCREASED APPETITE |
15 |
0.0008 |
| 476 |
PSYCHOMOTOR HYPERACTIVITY |
13 |
0.0008 |
| 477 |
MUSCLE TWITCHING |
18 |
0.0008 |
| 478 |
DELIRIUM |
27 |
0.0008 |
| 479 |
BRONCHOPULMONARY ASPERGILLOSIS |
6 |
0.0008 |
| 480 |
ANAEMIA |
147 |
0.0008 |
| 481 |
SYNCOPE |
77 |
0.0008 |
| 482 |
HEART RATE INCREASED |
76 |
0.0008 |
| 483 |
MULTIPLE ALLERGIES |
6 |
0.0008 |
| 484 |
PNEUMONIA BACTERIAL |
7 |
0.0008 |
| 485 |
COVID-19 PNEUMONIA |
9 |
0.0008 |
| 486 |
HYPOGAMMAGLOBULINAEMIA |
5 |
0.0008 |
| 487 |
INCONTINENCE |
8 |
0.0008 |
| 488 |
NASAL DISCOMFORT |
6 |
0.0008 |
| 489 |
DRUG INTOLERANCE |
73 |
0.0008 |
| 490 |
CHEST DISCOMFORT |
77 |
0.0008 |
| 491 |
RETCHING |
16 |
0.0007 |
| 492 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
53 |
0.0007 |
| 493 |
HYPOPHAGIA |
19 |
0.0007 |
| 494 |
CHILLS |
87 |
0.0007 |
| 495 |
LOSS OF CONSCIOUSNESS |
95 |
0.0007 |
| 496 |
COLITIS ISCHAEMIC |
5 |
0.0007 |
| 497 |
HYPERGLYCAEMIA |
27 |
0.0007 |
| 498 |
HEADACHE |
463 |
0.0007 |
| 499 |
IMPAIRED GASTRIC EMPTYING |
10 |
0.0007 |
| 500 |
POST PROCEDURAL COMPLICATION |
14 |
0.0007 |
| 501 |
SPINAL COMPRESSION FRACTURE |
6 |
0.0007 |
| 502 |
DROOLING |
5 |
0.0007 |
| 503 |
COORDINATION ABNORMAL |
10 |
0.0007 |
| 504 |
DYSPHAGIA |
68 |
0.0007 |
| 505 |
UPPER RESPIRATORY TRACT INFECTION |
33 |
0.0007 |
| 506 |
OEDEMA PERIPHERAL |
87 |
0.0007 |
| 507 |
HEART RATE DECREASED |
25 |
0.0007 |
| 508 |
BLOOD TEST ABNORMAL |
10 |
0.0007 |
| 509 |
DISSEMINATED INTRAVASCULAR COAGULATION |
10 |
0.0007 |
| 510 |
INFLUENZA |
79 |
0.0007 |
| 511 |
EXPOSURE DURING PREGNANCY |
44 |
0.0007 |
| 512 |
HYPOTONIA |
7 |
0.0007 |
| 513 |
LEUKOPENIA |
35 |
0.0007 |
| 514 |
PSEUDOMONAS INFECTION |
6 |
0.0007 |
| 515 |
LIVER FUNCTION TEST INCREASED |
15 |
0.0007 |
| 516 |
ANGINA PECTORIS |
20 |
0.0007 |
| 517 |
BLOOD MAGNESIUM DECREASED |
6 |
0.0007 |
| 518 |
HIATUS HERNIA |
9 |
0.0007 |
| 519 |
COMA |
33 |
0.0007 |
| 520 |
LIVER INJURY |
17 |
0.0007 |
| 521 |
PULMONARY OEDEMA |
31 |
0.0007 |
| 522 |
TASTE DISORDER |
14 |
0.0007 |
| 523 |
DIARRHOEA |
445 |
0.0007 |
| 524 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
6 |
0.0007 |
| 525 |
FLUSHING |
70 |
0.0007 |
| 526 |
ELECTROLYTE IMBALANCE |
8 |
0.0007 |
| 527 |
NECK PAIN |
38 |
0.0007 |
| 528 |
CARDIOTOXICITY |
6 |
0.0007 |
| 529 |
MYOCLONUS |
8 |
0.0007 |
| 530 |
HEPATIC FUNCTION ABNORMAL |
25 |
0.0007 |
| 531 |
HEAVY MENSTRUAL BLEEDING |
6 |
0.0007 |
| 532 |
BLOOD BILIRUBIN INCREASED |
18 |
0.0007 |
| 533 |
VOMITING |
313 |
0.0007 |
| 534 |
CONTUSION |
64 |
0.0007 |
| 535 |
PERIPHERAL SWELLING |
102 |
0.0007 |
| 536 |
OSTEOPENIA |
10 |
0.0007 |
| 537 |
RESPIRATORY FAILURE |
48 |
0.0007 |
| 538 |
PRESYNCOPE |
16 |
0.0007 |
| 539 |
HAEMATOCRIT DECREASED |
13 |
0.0007 |
| 540 |
DIPLOPIA |
17 |
0.0007 |
| 541 |
NAUSEA |
516 |
0.0007 |
| 542 |
CANDIDA INFECTION |
11 |
0.0007 |
| 543 |
CARDIOMEGALY |
8 |
0.0006 |
| 544 |
DEVICE RELATED INFECTION |
10 |
0.0006 |
| 545 |
PRODUCT USE IN UNAPPROVED INDICATION |
161 |
0.0006 |
| 546 |
PRODUCTIVE COUGH |
31 |
0.0006 |
| 547 |
DISTURBANCE IN ATTENTION |
35 |
0.0006 |
| 548 |
DECREASED ACTIVITY |
7 |
0.0006 |
| 549 |
CYTOKINE RELEASE SYNDROME |
13 |
0.0006 |
| 550 |
GENERALISED OEDEMA |
8 |
0.0006 |
| 551 |
BACK PAIN |
150 |
0.0006 |
| 552 |
DIZZINESS |
322 |
0.0006 |
| 553 |
PRODUCT ADMINISTRATION ERROR |
13 |
0.0006 |
| 554 |
CARPAL TUNNEL SYNDROME |
9 |
0.0006 |
| 555 |
SWELLING |
60 |
0.0006 |
| 556 |
ELECTROCARDIOGRAM ABNORMAL |
5 |
0.0006 |
| 557 |
BLOOD SODIUM DECREASED |
12 |
0.0006 |
| 558 |
BLOOD POTASSIUM DECREASED |
19 |
0.0006 |
| 559 |
PAIN IN EXTREMITY |
186 |
0.0006 |
| 560 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 561 |
INJECTION SITE IRRITATION |
8 |
0.0006 |
| 562 |
RESTLESSNESS |
23 |
0.0006 |
| 563 |
THROAT IRRITATION |
28 |
0.0006 |
| 564 |
SKIN INFECTION |
7 |
0.0006 |
| 565 |
GLAUCOMA |
12 |
0.0006 |
| 566 |
SEPTIC SHOCK |
27 |
0.0006 |
| 567 |
EYE INFECTION |
7 |
0.0006 |
| 568 |
RHINORRHOEA |
40 |
0.0006 |
| 569 |
HYPERTENSION |
131 |
0.0006 |
| 570 |
AUTOIMMUNE DISORDER |
6 |
0.0006 |
| 571 |
VITAMIN D DEFICIENCY |
6 |
0.0006 |
| 572 |
ASPHYXIA |
5 |
0.0006 |
| 573 |
RENAL TUBULAR NECROSIS |
6 |
0.0006 |
| 574 |
HEPATOMEGALY |
6 |
0.0006 |
| 575 |
PAIN |
375 |
0.0006 |
| 576 |
ESCHERICHIA INFECTION |
5 |
0.0006 |
| 577 |
TOOTH INFECTION |
8 |
0.0006 |
| 578 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 579 |
CONSTIPATION |
131 |
0.0006 |
| 580 |
MYALGIA |
102 |
0.0006 |
| 581 |
URINARY RETENTION |
20 |
0.0006 |
| 582 |
EMPHYSEMA |
6 |
0.0006 |
| 583 |
DECREASED APPETITE |
138 |
0.0006 |
| 584 |
TOOTH ABSCESS |
6 |
0.0006 |
| 585 |
SUBARACHNOID HAEMORRHAGE |
6 |
0.0006 |
| 586 |
CHEST PAIN |
109 |
0.0006 |
| 587 |
PNEUMONIA |
190 |
0.0006 |
| 588 |
GINGIVAL BLEEDING |
8 |
0.0006 |
| 589 |
ELECTROCARDIOGRAM QT PROLONGED |
21 |
0.0006 |
| 590 |
MUSCULOSKELETAL DISCOMFORT |
10 |
0.0006 |
| 591 |
GASTROINTESTINAL DISORDER |
52 |
0.0006 |
| 592 |
DRY MOUTH |
47 |
0.0006 |
| 593 |
BURSITIS |
7 |
0.0006 |
| 594 |
RESPIRATORY TRACT INFECTION |
15 |
0.0006 |
| 595 |
PLEURAL EFFUSION |
35 |
0.0006 |
| 596 |
URINARY INCONTINENCE |
17 |
0.0006 |
| 597 |
WHITE BLOOD CELL COUNT INCREASED |
22 |
0.0006 |
| 598 |
MATERNAL EXPOSURE DURING PREGNANCY |
51 |
0.0006 |
| 599 |
VISUAL ACUITY REDUCED |
19 |
0.0006 |
| 600 |
BLOOD CALCIUM INCREASED |
5 |
0.0006 |
| 601 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 602 |
ABDOMINAL PAIN |
132 |
0.0006 |
| 603 |
OSTEOARTHRITIS |
24 |
0.0006 |
| 604 |
LUNG INFILTRATION |
5 |
0.0006 |
| 605 |
BLOOD TRIGLYCERIDES INCREASED |
10 |
0.0006 |
| 606 |
PREMATURE DELIVERY |
9 |
0.0006 |
| 607 |
ATRIAL FIBRILLATION |
55 |
0.0006 |
| 608 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
27 |
0.0006 |
| 609 |
JOINT INJURY |
12 |
0.0006 |
| 610 |
OSTEOPOROSIS |
23 |
0.0006 |
| 611 |
HYPERSOMNIA |
16 |
0.0006 |
| 612 |
PYREXIA |
193 |
0.0006 |
| 613 |
INTESTINAL OBSTRUCTION |
21 |
0.0006 |
| 614 |
CONFUSIONAL STATE |
90 |
0.0006 |
| 615 |
WHEEZING |
33 |
0.0006 |
| 616 |
ANAL INCONTINENCE |
5 |
0.0006 |
| 617 |
WEIGHT DECREASED |
155 |
0.0006 |
| 618 |
THROAT TIGHTNESS |
15 |
0.0006 |
| 619 |
BRAIN OEDEMA |
7 |
0.0006 |
| 620 |
RASH PRURITIC |
30 |
0.0006 |
| 621 |
MUSCLE ATROPHY |
7 |
0.0006 |
| 622 |
LIMB INJURY |
15 |
0.0006 |
| 623 |
SKIN LACERATION |
6 |
0.0006 |
| 624 |
COMPLICATION ASSOCIATED WITH DEVICE |
8 |
0.0006 |
| 625 |
PELVIC PAIN |
10 |
0.0005 |
| 626 |
OESOPHAGITIS |
6 |
0.0005 |
| 627 |
INTERVERTEBRAL DISC PROTRUSION |
12 |
0.0005 |
| 628 |
PANIC ATTACK |
20 |
0.0005 |
| 629 |
BONE PAIN |
32 |
0.0005 |
| 630 |
GASTROINTESTINAL PAIN |
6 |
0.0005 |
| 631 |
BLOOD PRESSURE INCREASED |
83 |
0.0005 |
| 632 |
FEEDING DISORDER |
11 |
0.0005 |
| 633 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
12 |
0.0005 |
| 634 |
DYSKINESIA |
22 |
0.0005 |
| 635 |
TOOTH DISORDER |
12 |
0.0005 |
| 636 |
FEELING COLD |
15 |
0.0005 |
| 637 |
BLOOD CHOLESTEROL INCREASED |
25 |
0.0005 |
| 638 |
BLOOD CREATININE INCREASED |
35 |
0.0005 |
| 639 |
HEPATIC ENCEPHALOPATHY |
5 |
0.0005 |
| 640 |
HAEMORRHAGE INTRACRANIAL |
8 |
0.0005 |
| 641 |
COUGH |
150 |
0.0005 |
| 642 |
OCULAR DISCOMFORT |
6 |
0.0005 |
| 643 |
GASTROOESOPHAGEAL REFLUX DISEASE |
43 |
0.0005 |
| 644 |
FLANK PAIN |
5 |
0.0005 |
| 645 |
ABORTION INDUCED |
5 |
0.0005 |
| 646 |
TREMOR |
88 |
0.0005 |
| 647 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
9 |
0.0005 |
| 648 |
THERAPEUTIC RESPONSE DECREASED |
32 |
0.0005 |
| 649 |
SINUSITIS |
54 |
0.0005 |
| 650 |
EAR INFECTION |
14 |
0.0005 |
| 651 |
VERTIGO |
32 |
0.0005 |
| 652 |
NEOPLASM |
6 |
0.0005 |
| 653 |
FEELING ABNORMAL |
125 |
0.0005 |
| 654 |
ANXIETY |
148 |
0.0005 |
| 655 |
CHOLELITHIASIS |
17 |
0.0005 |
| 656 |
WEIGHT INCREASED |
116 |
0.0005 |
| 657 |
RASH MACULAR |
18 |
0.0005 |
| 658 |
PRODUCT USE ISSUE |
96 |
0.0005 |
| 659 |
INFLUENZA LIKE ILLNESS |
42 |
0.0005 |
| 660 |
FUNGAL INFECTION |
17 |
0.0005 |
| 661 |
FATIGUE |
394 |
0.0005 |
| 662 |
INSOMNIA |
134 |
0.0005 |
| 663 |
ULCER |
8 |
0.0005 |
| 664 |
SCIATICA |
8 |
0.0005 |
| 665 |
GOUT |
9 |
0.0005 |
| 666 |
ERYTHEMA |
103 |
0.0005 |
| 667 |
MASS |
7 |
0.0005 |
| 668 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
26 |
0.0005 |
| 669 |
THROMBOSIS |
40 |
0.0005 |
| 670 |
EYE PAIN |
28 |
0.0005 |
| 671 |
FULL BLOOD COUNT DECREASED |
10 |
0.0005 |
| 672 |
OFF LABEL USE |
434 |
0.0005 |
| 673 |
BONE DISORDER |
9 |
0.0005 |
| 674 |
DEVICE BREAKAGE |
20 |
0.0005 |
| 675 |
CYTOPENIA |
6 |
0.0005 |
| 676 |
SUBDURAL HAEMATOMA |
7 |
0.0005 |
| 677 |
METASTASES TO BONE |
8 |
0.0005 |
| 678 |
EAR DISCOMFORT |
5 |
0.0005 |
| 679 |
PRODUCT PREPARATION ERROR |
10 |
0.0005 |
| 680 |
OVERDOSE |
105 |
0.0005 |
| 681 |
HYPERCALCAEMIA |
6 |
0.0005 |
| 682 |
ARRHYTHMIA |
23 |
0.0005 |
| 683 |
LIMB DISCOMFORT |
15 |
0.0005 |
| 684 |
PHARYNGITIS |
6 |
0.0005 |
| 685 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
12 |
0.0005 |
| 686 |
ARTHRITIS |
38 |
0.0005 |
| 687 |
HYPOKINESIA |
7 |
0.0005 |
| 688 |
HYPERHIDROSIS |
62 |
0.0005 |
| 689 |
HYPOAESTHESIA |
72 |
0.0005 |
| 690 |
LIP SWELLING |
16 |
0.0005 |
| 691 |
DISORIENTATION |
19 |
0.0005 |
| 692 |
SECRETION DISCHARGE |
6 |
0.0005 |
| 693 |
STOMATITIS |
29 |
0.0005 |
| 694 |
PNEUMONITIS |
13 |
0.0005 |
| 695 |
NASOPHARYNGITIS |
88 |
0.0005 |
| 696 |
NASAL CONGESTION |
28 |
0.0005 |
| 697 |
SEPSIS |
53 |
0.0005 |
| 698 |
PULMONARY MASS |
7 |
0.0005 |
| 699 |
PROCEDURAL PAIN |
13 |
0.0005 |
| 700 |
WOUND |
13 |
0.0005 |
| 701 |
CARDIAC FAILURE |
37 |
0.0005 |
| 702 |
PLATELET COUNT INCREASED |
6 |
0.0005 |
| 703 |
BACK INJURY |
5 |
0.0005 |
| 704 |
HYPERSENSITIVITY |
85 |
0.0005 |
| 705 |
MUSCULAR WEAKNESS |
52 |
0.0005 |
| 706 |
DYSPEPSIA |
45 |
0.0005 |
| 707 |
TINNITUS |
21 |
0.0005 |
| 708 |
INTENTIONAL PRODUCT MISUSE |
40 |
0.0005 |
| 709 |
INFECTION |
66 |
0.0005 |
| 710 |
ORAL CANDIDIASIS |
6 |
0.0005 |
| 711 |
PHARYNGEAL OEDEMA |
7 |
0.0005 |
| 712 |
WITHDRAWAL SYNDROME |
19 |
0.0005 |
| 713 |
HEAD DISCOMFORT |
8 |
0.0005 |
| 714 |
EXPIRED PRODUCT ADMINISTERED |
15 |
0.0005 |
| 715 |
LUNG INFECTION |
7 |
0.0005 |
| 716 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 717 |
NEEDLE ISSUE |
13 |
0.0004 |
| 718 |
DRUG ABUSE |
37 |
0.0004 |
| 719 |
SYNOVITIS |
8 |
0.0004 |
| 720 |
DRUG TOXICITY |
6 |
0.0004 |
| 721 |
MALAISE |
193 |
0.0004 |
| 722 |
PERIPHERAL COLDNESS |
6 |
0.0004 |
| 723 |
ABDOMINAL DISCOMFORT |
73 |
0.0004 |
| 724 |
DYSURIA |
16 |
0.0004 |
| 725 |
MUSCLE TIGHTNESS |
7 |
0.0004 |
| 726 |
ORAL DISCOMFORT |
6 |
0.0004 |
| 727 |
CONTRAINDICATED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 728 |
HAEMOGLOBIN DECREASED |
44 |
0.0004 |
| 729 |
ASTHMA |
48 |
0.0004 |
| 730 |
FEELING HOT |
26 |
0.0004 |
| 731 |
ASTHENIA |
159 |
0.0004 |
| 732 |
ATAXIA |
5 |
0.0004 |
| 733 |
GASTRIC ULCER |
8 |
0.0004 |
| 734 |
VIRAL INFECTION |
14 |
0.0004 |
| 735 |
TREATMENT NONCOMPLIANCE |
23 |
0.0004 |
| 736 |
MUCOSAL INFLAMMATION |
11 |
0.0004 |
| 737 |
PRODUCT ADHESION ISSUE |
15 |
0.0004 |
| 738 |
NEUTROPENIA |
57 |
0.0004 |
| 739 |
GASTROINTESTINAL HAEMORRHAGE |
35 |
0.0004 |
| 740 |
CONDITION AGGRAVATED |
127 |
0.0004 |
| 741 |
ARTHRALGIA |
173 |
0.0004 |
| 742 |
SOMNOLENCE |
83 |
0.0004 |
| 743 |
ADRENAL INSUFFICIENCY |
5 |
0.0004 |
| 744 |
BLOOD PRESSURE SYSTOLIC INCREASED |
8 |
0.0004 |
| 745 |
FEAR |
11 |
0.0004 |
| 746 |
HAEMATURIA |
14 |
0.0004 |
| 747 |
APPLICATION SITE PAIN |
9 |
0.0004 |
| 748 |
AGITATION |
30 |
0.0004 |
| 749 |
ENCEPHALOPATHY |
10 |
0.0004 |
| 750 |
ACUTE MYOCARDIAL INFARCTION |
12 |
0.0004 |
| 751 |
GLOMERULAR FILTRATION RATE DECREASED |
5 |
0.0004 |
| 752 |
STEVENS-JOHNSON SYNDROME |
9 |
0.0004 |
| 753 |
OSTEONECROSIS OF JAW |
10 |
0.0004 |
| 754 |
NIGHT SWEATS |
13 |
0.0004 |
| 755 |
BLOOD PRESSURE ABNORMAL |
8 |
0.0004 |
| 756 |
ORAL PAIN |
9 |
0.0004 |
| 757 |
RESPIRATORY DISORDER |
12 |
0.0004 |
| 758 |
OROPHARYNGEAL PAIN |
37 |
0.0004 |
| 759 |
EOSINOPHILIA |
7 |
0.0004 |
| 760 |
URINARY TRACT INFECTION |
68 |
0.0004 |
| 761 |
JOINT SWELLING |
48 |
0.0004 |
| 762 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 763 |
BONE MARROW FAILURE |
8 |
0.0004 |
| 764 |
INSURANCE ISSUE |
6 |
0.0004 |
| 765 |
DEHYDRATION |
52 |
0.0004 |
| 766 |
NEUROPATHY PERIPHERAL |
37 |
0.0004 |
| 767 |
LUNG DISORDER |
19 |
0.0004 |
| 768 |
EXPOSURE VIA SKIN CONTACT |
10 |
0.0004 |
| 769 |
RED BLOOD CELL COUNT DECREASED |
11 |
0.0004 |
| 770 |
SPEECH DISORDER |
20 |
0.0004 |
| 771 |
IMMUNE SYSTEM DISORDER |
5 |
0.0004 |
| 772 |
HEAD INJURY |
12 |
0.0004 |
| 773 |
HALLUCINATION, VISUAL |
8 |
0.0004 |
| 774 |
DEPRESSED MOOD |
20 |
0.0004 |
| 775 |
BRONCHITIS |
28 |
0.0004 |
| 776 |
PRODUCT PRESCRIBING ERROR |
9 |
0.0004 |
| 777 |
HALLUCINATION, AUDITORY |
6 |
0.0004 |
| 778 |
ADVERSE REACTION |
5 |
0.0004 |
| 779 |
COVID-19 |
66 |
0.0004 |
| 780 |
DYSPHONIA |
22 |
0.0004 |
| 781 |
ABSCESS |
6 |
0.0004 |
| 782 |
HEPATIC STEATOSIS |
7 |
0.0004 |
| 783 |
PARAESTHESIA |
59 |
0.0004 |
| 784 |
SENSORY DISTURBANCE |
6 |
0.0004 |
| 785 |
HEPATIC CIRRHOSIS |
7 |
0.0004 |
| 786 |
LOCALISED INFECTION |
9 |
0.0004 |
| 787 |
HYPOACUSIS |
16 |
0.0004 |
| 788 |
DRUG INEFFECTIVE |
488 |
0.0004 |
| 789 |
URTICARIA |
62 |
0.0004 |
| 790 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 791 |
BLOOD POTASSIUM INCREASED |
6 |
0.0004 |
| 792 |
PRODUCT DISPENSING ERROR |
8 |
0.0004 |
| 793 |
ACUTE KIDNEY INJURY |
56 |
0.0004 |
| 794 |
ERUCTATION |
7 |
0.0004 |
| 795 |
ANGIOEDEMA |
16 |
0.0004 |
| 796 |
DYSTONIA |
7 |
0.0004 |
| 797 |
RASH PAPULAR |
8 |
0.0004 |
| 798 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 799 |
RASH ERYTHEMATOUS |
17 |
0.0004 |
| 800 |
ABNORMAL BEHAVIOUR |
14 |
0.0004 |
| 801 |
FALL |
117 |
0.0004 |
| 802 |
SCAR |
6 |
0.0004 |
| 803 |
ACCIDENTAL EXPOSURE TO PRODUCT |
36 |
0.0003 |
| 804 |
MOBILITY DECREASED |
25 |
0.0003 |
| 805 |
LETHARGY |
20 |
0.0003 |
| 806 |
PULMONARY EMBOLISM |
33 |
0.0003 |
| 807 |
EXTRA DOSE ADMINISTERED |
14 |
0.0003 |
| 808 |
HYPERTHYROIDISM |
5 |
0.0003 |
| 809 |
MENTAL DISORDER |
15 |
0.0003 |
| 810 |
BLINDNESS |
14 |
0.0003 |
| 811 |
MUSCLE SPASMS |
63 |
0.0003 |
| 812 |
COGNITIVE DISORDER |
16 |
0.0003 |
| 813 |
INTENTIONAL PRODUCT USE ISSUE |
30 |
0.0003 |
| 814 |
VISION BLURRED |
47 |
0.0003 |
| 815 |
HYPERKALAEMIA |
12 |
0.0003 |
| 816 |
GASTRITIS |
9 |
0.0003 |
| 817 |
DIABETES MELLITUS |
26 |
0.0003 |
| 818 |
SLEEP DISORDER |
24 |
0.0003 |
| 819 |
DIABETES MELLITUS INADEQUATE CONTROL |
6 |
0.0003 |
| 820 |
GALLBLADDER DISORDER |
6 |
0.0003 |
| 821 |
RHABDOMYOLYSIS |
14 |
0.0003 |
| 822 |
IMMUNODEFICIENCY |
5 |
0.0003 |
| 823 |
VISUAL IMPAIRMENT |
41 |
0.0003 |
| 824 |
RASH |
144 |
0.0003 |
| 825 |
ABDOMINAL PAIN UPPER |
68 |
0.0003 |
| 826 |
CRYING |
12 |
0.0003 |
| 827 |
END STAGE RENAL DISEASE |
6 |
0.0003 |
| 828 |
INJECTION SITE PAIN |
100 |
0.0003 |
| 829 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
7 |
0.0003 |
| 830 |
ANKLE FRACTURE |
5 |
0.0003 |
| 831 |
THROMBOCYTOPENIA |
36 |
0.0003 |
| 832 |
DELUSION |
5 |
0.0003 |
| 833 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 834 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
15 |
0.0003 |
| 835 |
SWOLLEN TONGUE |
10 |
0.0003 |
| 836 |
INJECTION SITE REACTION |
22 |
0.0003 |
| 837 |
PHOTOPHOBIA |
6 |
0.0003 |
| 838 |
HOT FLUSH |
24 |
0.0003 |
| 839 |
FOOT FRACTURE |
6 |
0.0003 |
| 840 |
HAEMATEMESIS |
8 |
0.0003 |
| 841 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 842 |
PRODUCT DOSE OMISSION ISSUE |
92 |
0.0003 |
| 843 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
9 |
0.0003 |
| 844 |
PANCREATITIS ACUTE |
7 |
0.0003 |
| 845 |
CHROMATURIA |
7 |
0.0003 |
| 846 |
CARDIAC DISORDER |
29 |
0.0003 |
| 847 |
INTERSTITIAL LUNG DISEASE |
15 |
0.0003 |
| 848 |
HEART RATE IRREGULAR |
7 |
0.0003 |
| 849 |
SKIN ULCER |
8 |
0.0003 |
| 850 |
EAR PAIN |
6 |
0.0003 |
| 851 |
BACK DISORDER |
5 |
0.0003 |
| 852 |
AMNESIA |
20 |
0.0003 |
| 853 |
SEDATION |
8 |
0.0003 |
| 854 |
LABORATORY TEST ABNORMAL |
9 |
0.0003 |
| 855 |
PSYCHOTIC DISORDER |
9 |
0.0003 |
| 856 |
ANHEDONIA |
8 |
0.0003 |
| 857 |
PANCYTOPENIA |
17 |
0.0003 |
| 858 |
IRRITABILITY |
18 |
0.0003 |
| 859 |
HEPATIC FAILURE |
9 |
0.0003 |
| 860 |
MUSCULOSKELETAL STIFFNESS |
26 |
0.0003 |
| 861 |
TRANSIENT ISCHAEMIC ATTACK |
10 |
0.0003 |
| 862 |
GAIT DISTURBANCE |
56 |
0.0003 |
| 863 |
DEVICE DELIVERY SYSTEM ISSUE |
8 |
0.0003 |
| 864 |
RIB FRACTURE |
6 |
0.0003 |
| 865 |
PRURITUS |
111 |
0.0003 |
| 866 |
NERVOUS SYSTEM DISORDER |
9 |
0.0003 |
| 867 |
FIBROMYALGIA |
7 |
0.0003 |
| 868 |
NERVOUSNESS |
15 |
0.0003 |
| 869 |
HAEMORRHAGE |
30 |
0.0003 |
| 870 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 871 |
GENERAL PHYSICAL HEALTH DETERIORATION |
33 |
0.0003 |
| 872 |
INJURY |
20 |
0.0003 |
| 873 |
EMOTIONAL DISTRESS |
34 |
0.0003 |
| 874 |
HIP FRACTURE |
9 |
0.0003 |
| 875 |
IRRITABLE BOWEL SYNDROME |
6 |
0.0003 |
| 876 |
CONVULSION |
16 |
0.0003 |
| 877 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
10 |
0.0003 |
| 878 |
HALLUCINATION |
21 |
0.0003 |
| 879 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
7 |
0.0003 |
| 880 |
LEUKOCYTOSIS |
5 |
0.0003 |
| 881 |
CLOSTRIDIUM DIFFICILE INFECTION |
6 |
0.0003 |
| 882 |
MELAENA |
6 |
0.0003 |
| 883 |
LIVER DISORDER |
12 |
0.0003 |
| 884 |
GAIT INABILITY |
9 |
0.0003 |
| 885 |
AGRANULOCYTOSIS |
5 |
0.0003 |
| 886 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
12 |
0.0003 |
| 887 |
DEAFNESS |
7 |
0.0003 |
| 888 |
TYPE 2 DIABETES MELLITUS |
9 |
0.0003 |
| 889 |
APPLICATION SITE ERYTHEMA |
7 |
0.0003 |
| 890 |
TREATMENT FAILURE |
22 |
0.0003 |
| 891 |
LACRIMATION INCREASED |
8 |
0.0003 |
| 892 |
BLOOD URINE PRESENT |
5 |
0.0003 |
| 893 |
EPILEPSY |
8 |
0.0003 |
| 894 |
SKIN EXFOLIATION |
22 |
0.0003 |
| 895 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 896 |
DEPRESSION |
59 |
0.0003 |
| 897 |
DRUG-INDUCED LIVER INJURY |
8 |
0.0003 |
| 898 |
BALANCE DISORDER |
22 |
0.0003 |
| 899 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
9 |
0.0003 |
| 900 |
INFLAMMATION |
13 |
0.0003 |
| 901 |
PRODUCT QUALITY ISSUE |
34 |
0.0003 |
| 902 |
BLOOD PRESSURE FLUCTUATION |
6 |
0.0002 |
| 903 |
DIABETIC KETOACIDOSIS |
6 |
0.0002 |
| 904 |
INJECTION SITE SWELLING |
19 |
0.0002 |
| 905 |
MEMORY IMPAIRMENT |
34 |
0.0002 |
| 906 |
PANCREATITIS |
13 |
0.0002 |
| 907 |
THERAPEUTIC RESPONSE UNEXPECTED |
11 |
0.0002 |
| 908 |
IMPAIRED HEALING |
8 |
0.0002 |
| 909 |
EYE IRRITATION |
14 |
0.0002 |
| 910 |
INJECTION SITE WARMTH |
5 |
0.0002 |
| 911 |
CEREBROVASCULAR ACCIDENT |
41 |
0.0002 |
| 912 |
LIVER FUNCTION TEST ABNORMAL |
7 |
0.0002 |
| 913 |
PNEUMONIA ASPIRATION |
6 |
0.0002 |
| 914 |
NEPHROLITHIASIS |
11 |
0.0002 |
| 915 |
RENAL IMPAIRMENT |
20 |
0.0002 |
| 916 |
RENAL DISORDER |
11 |
0.0002 |
| 917 |
FOETAL EXPOSURE DURING PREGNANCY |
19 |
0.0002 |
| 918 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
6 |
0.0002 |
| 919 |
RECTAL HAEMORRHAGE |
10 |
0.0002 |
| 920 |
HAEMATOMA |
6 |
0.0002 |
| 921 |
NEOPLASM PROGRESSION |
8 |
0.0002 |
| 922 |
BLOOD GLUCOSE DECREASED |
11 |
0.0002 |
| 923 |
RENAL FAILURE |
30 |
0.0002 |
| 924 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 925 |
MOVEMENT DISORDER |
7 |
0.0002 |
| 926 |
INJECTION SITE ERYTHEMA |
27 |
0.0002 |
| 927 |
HAEMATOCHEZIA |
12 |
0.0002 |
| 928 |
ARTHROPATHY |
12 |
0.0002 |
| 929 |
ROAD TRAFFIC ACCIDENT |
9 |
0.0002 |
| 930 |
DEMENTIA |
6 |
0.0002 |
| 931 |
EYE DISORDER |
7 |
0.0002 |
| 932 |
INJECTION SITE HAEMORRHAGE |
17 |
0.0002 |
| 933 |
COLITIS |
8 |
0.0002 |
| 934 |
CHRONIC KIDNEY DISEASE |
16 |
0.0002 |
| 935 |
INTERNATIONAL NORMALISED RATIO INCREASED |
6 |
0.0002 |
| 936 |
ECZEMA |
11 |
0.0002 |
| 937 |
BLOOD GLUCOSE INCREASED |
39 |
0.0002 |
| 938 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 939 |
MALIGNANT NEOPLASM PROGRESSION |
21 |
0.0002 |
| 940 |
INJECTION SITE BRUISING |
16 |
0.0002 |
| 941 |
DRY EYE |
10 |
0.0002 |
| 942 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
36 |
0.0002 |
| 943 |
SWELLING FACE |
13 |
0.0002 |
| 944 |
CARDIAC FAILURE CONGESTIVE |
16 |
0.0002 |
| 945 |
CARDIOVASCULAR DISORDER |
5 |
0.0002 |
| 946 |
ADVERSE EVENT |
18 |
0.0002 |
| 947 |
FEMUR FRACTURE |
6 |
0.0002 |
| 948 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
39 |
0.0002 |
| 949 |
MUSCULOSKELETAL PAIN |
10 |
0.0002 |
| 950 |
OCULAR HYPERAEMIA |
9 |
0.0002 |
| 951 |
DYSGEUSIA |
14 |
0.0002 |
| 952 |
EYE SWELLING |
7 |
0.0002 |
| 953 |
DEEP VEIN THROMBOSIS |
12 |
0.0002 |
| 954 |
VAGINAL HAEMORRHAGE |
8 |
0.0002 |
| 955 |
HOSPITALISATION |
28 |
0.0002 |
| 956 |
FLATULENCE |
10 |
0.0002 |
| 957 |
RHEUMATOID ARTHRITIS |
20 |
0.0002 |
| 958 |
UNEVALUABLE EVENT |
13 |
0.0002 |
| 959 |
INCORRECT DOSE ADMINISTERED |
38 |
0.0002 |
| 960 |
INJECTION SITE MASS |
6 |
0.0002 |
| 961 |
HEPATIC ENZYME INCREASED |
11 |
0.0002 |
| 962 |
COLITIS ULCERATIVE |
7 |
0.0002 |
| 963 |
THERAPY INTERRUPTED |
11 |
0.0002 |
| 964 |
SKIN BURNING SENSATION |
11 |
0.0002 |
| 965 |
SURGERY |
9 |
0.0002 |
| 966 |
SUICIDAL IDEATION |
14 |
0.0002 |
| 967 |
SKIN IRRITATION |
7 |
0.0002 |
| 968 |
INFUSION RELATED REACTION |
10 |
0.0002 |
| 969 |
EYE PRURITUS |
5 |
0.0001 |
| 970 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
5 |
0.0001 |
| 971 |
ADVERSE DRUG REACTION |
13 |
0.0001 |
| 972 |
POLLAKIURIA |
6 |
0.0001 |
| 973 |
RENAL FAILURE ACUTE |
6 |
0.0001 |
| 974 |
DEATH |
120 |
0.0001 |
| 975 |
NEOPLASM MALIGNANT |
9 |
0.0001 |
| 976 |
INJECTION SITE PRURITUS |
9 |
0.0001 |
| 977 |
SUICIDE ATTEMPT |
8 |
0.0001 |
| 978 |
LOWER RESPIRATORY TRACT INFECTION |
6 |
0.0001 |
| 979 |
ALOPECIA |
25 |
0.0001 |
| 980 |
DISEASE PROGRESSION |
14 |
0.0001 |
| 981 |
PSORIASIS |
14 |
0.0001 |
| 982 |
DISEASE RECURRENCE |
5 |
0.0001 |
| 983 |
BREAST CANCER |
9 |
0.0001 |
| 984 |
COMPLETED SUICIDE |
8 |
0.0001 |
| 985 |
DRUG EFFECT DECREASED |
5 |
0.0001 |
| 986 |
DRY SKIN |
12 |
0.0001 |
| 987 |
MYOCARDIAL INFARCTION |
14 |
0.0001 |
| 988 |
PRODUCT STORAGE ERROR |
7 |
0.0001 |
| 989 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 990 |
DRUG DEPENDENCE |
11 |
0.0001 |
| 991 |
ACNE |
5 |
0.0001 |
| 992 |
NO ADVERSE EVENT |
11 |
0.0001 |